iNEXT-Discovery is a structural biology project funded from the European Commission Horizon 2020 scheme that has been extended until July 31, 2024. The partnership is a top-notch European academic network that efficiently builds on experiences from the original iNEXT consortium. iNEXT-Discovery combines leading facilities for X-rays, NMR, cryo-EM and macromolecular biophysics that make access services available to external user communities, often researchers without prior experience in the field. Together, the partners also develop methods through joint research, provide integration of structural biology methods and reach out to other scientific fields, for instance through a vast set of meetings, theoretical courses, and practical workshops.
One particular aim of iNEXT-Discovery is to provide access services to structural biology technologies to researchers, external users from the EU, EU-associated countries and beyond, via different expert facilities. Importantly, we do not only offer access to our state-of-the-art instrumentation, but include expert support and guidance to help also non-experts to answer their scientific questions. Besides working closely with groups from different universities, research institutes and others, also scientists from companies can request access to our services.
Next to provision of facility access to stimulate translational research for health and other life sciences, we also actively invite researchers from other communities, such as the food, biotechnology and biomaterials sectors to apply.
Some slides about the iNEXT-Discovery project can be found here, a wonderful short promotional movie for more details is here.
In case you have questions don't hesitate to reach out and contact us!
COORDINATION AND MANAGEMENT
The iNEXT-Discovery coordinating team attempts to smoothly oversee all activities of the iNEXT-Discovery project. Progress is scrutinised by a small but diverse iNEXT-Discovery Executive Board with members that are experienced in running EC-projects and high-end research facilities. Each month they meet to discuss and decide on matters to efficiently bring the project forward. They are helped by an extended Management Board that continuously monitors activities and provides feedback for corrective actions. The General Assembly that includes all partners is the ultimate decision-making body of the consortium that meets once per year, more often if needed.
Coordinator |
Project Manager |
 |
 |
| Anastassis (Tassos) Perrakis, NKI | Hans Wienk, NKI |
Executive Board |
|||
 |
 |
 |
 |
| Rebeca Thompson, UNIVLEEDS | Eva Pereiro, ALBA | Harald Schwalbe, GUF/INSTRUCT | Manfred Weiss, HZB |
Management Board |
||
|
Lucia Banci, CIRMMP (Chair) |
|
|
PARTNER ORGANIZATIONS
- NKI - The Netherlands Cancer Institute
- CEITEC - Masaryk University
- EMBL - European Molecular Biology Laboratory
- EMBL-GR - EMBL Grenoble
- EMBL-HH - EMBL Hamburg
- EMBL-HD - EMBL Heidelberg
- EMBL-EBI - EMBL European Bioinformatics Institute Hinxton
- EMBL-EuBI - EuroBioImaging ERIC
- INSTRUCT - INSTRUC-ERIC
- CSIC - Spanish National Research Council
- NeCEN - Leiden University
- UNIVLEEDS - University of Leeds
- HZB - Helmholtz Zentrum Berlin
- MAX IV - Lund University
- UU - Utrecht University
- GUF - Goethe University Frankfurt
- SOLEIL - Synchrotron SOLEIL
- RALF-NMR - CNRS
- CIRMMP - Consorzio Interuniversitario Risonanze Magnetiche di Metallo Proteine
- ALBA - Synchrotron ALBA
- DIAMOND - Diamond Light Source
- CBI - Centre Europeen de Reserche en Biologie et Medecine
- NHRF - National Hellenic Research Foundation
- UNL - Universidade Nova de Lisboa
- METROFOOD - ENEA / METROFOOD-RI ESFRI
- AU - Aarhus University
- IIMCB - International Insitute of Molecular and Cell Biology
- ELTE - Eötvös Loránd University
- EU-OS - EU-OPENSCREEN ERIC
- VU - Vilnius University
- EATRIS - EATRIS-ERIC
SCIENTIFIC ADVISORY BOARD
iNEXT-Discovery managed to attract high-profile international structural biologists with versatile scientific expertise to form an independently operating Scientific Advisory Board. The very dedicated 5-membered SAB is of fundamental importance in guiding the consortium and make the project a success.
 |
 |
 |
 |
 |
| Elspeth Garman (Chair) | Rolf Boelens | Ilaria Ferlenghi | Kevin Gardner | Helen Saibil |
Elspeth Garman (Chair)
Professor Em. of Methods Development for Structural Biology, Department of Biochemistry, University of Oxford - Oxford, United Kingdom
Rolf Boelens
Professor Em. of NMR Spectroscopy, Utrecht University; Coordinator of the first H2020-project iNEXT - Utrecht, The Netherlands
Ilaria Ferlenghi
Head of Structural Microscopy at GSK Vaccines - Siena, Italy
Kevin Gardner
Director, Structural Biology Initiative, CUNY Advanced Science Research Center; Professor of Chemistry & Biochemistry, City College of New York - New York, United States
Helen Saibil
Professor of Structural Biology, Birkbeck College - London, United Kingdom
